A Powerful Pathway-Based Adaptive Test for Genetic Association with Common or Rare Variants
Wei Pan1, Il-Youp Kwak1, Peng Wei2
1Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN 55455, USA.
American Journal of Human Genetics
|June 30, 2015
Summary
Genome-wide association studies (GWASs) explain little heritability. This study introduces an adaptive pathway-based test to improve the identification of genetic variants associated with complex traits, enhancing power for common and rare variants.
Area of Science:
- Genetics
- Bioinformatics
- Statistical Genetics
Background:
- Genome-wide association studies (GWASs) have identified genetic variants for complex traits, but explain a small proportion of heritability.
- Genetic heterogeneity and small effect sizes of causal variants limit standard single-nucleotide polymorphism (SNP)-based analyses.
- Pathway analysis, considering sets of functionally related genes, offers a promising alternative for identifying complex trait associations.
Purpose of the Study:
- To propose a novel pathway-based statistical test for complex traits.
- To develop a method adaptive to varying numbers of associated genes and SNPs within pathways.
- To enhance the power of genetic association studies for both common and rare variants.
Main Methods:
- Developed an adaptive pathway-based test considering both gene and SNP levels.
- The method incorporates biological knowledge of SNPs and genes to increase statistical power.
- Evaluated performance using extensive simulations and a WTCCC GWAS dataset, comparing against existing SNP-set and pathway-based tests.
Main Results:
- The proposed adaptive pathway-based test demonstrated high power across diverse scenarios with varying numbers of associated genes and SNPs.
- The method showed promising performance compared to existing approaches in both simulated and real GWAS data.
- The approach is applicable to both common and rare genetic variants.
Conclusions:
- The proposed adaptive pathway-based test offers a powerful and flexible approach for genetic association studies of complex traits.
- This method can improve the identification of genetic variants contributing to heritability, especially in cases of genetic heterogeneity.
- The adaptive pathway analysis has potential for practical application in genetic research and discovery.
More Related Videos
Related Concept Videos
Genome-wide Association Studies-GWAS
16.7K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.7K
Principles of Pharmacogenetics: Types of Genetic Variants
102
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
102
Pharmacogenomics: Identification of New Drug Targets
88
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
88
Genetic Screens
5.9K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.9K
Single Nucleotide Polymorphisms-SNPs
19.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
19.9K
Pharmacogenetics and Pharmacogenomics: Overview
162
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
162


